Enhancement of humoral and cellular immunity in mice against Japanese encephalitis virus using a DNA prime-protein boost vaccine strategy

Veterinary Journal

Volumn 183, Issue 2, 2010, Pages 210-216

  Li, Peng ^a   Cao, Rui Bing ^a   Zheng, Qi Sheng ^b   Liu, Jing Jun ^a   Li, Yan ^c   Wang, En Xiu ^d   Li, Fei ^e   Chen, Pu Yan ^a  

^a NANJING AGRICULTURAL UNIVERSITY   (China)

^b National Veterinary Biological Medicine Engineering Research Center   (China)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e QINGDAO AGRICULTURAL UNIVERSITY   (China)

Author keywords

DNA vaccine; Epitope; Japanese encephalitis virus; Prime boost

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INACTIVATED VACCINE; INTERLEUKIN 2; INTERLEUKIN 4; NEUTRALIZING ANTIBODY; PLASMID DNA; RECOMBINANT E PROTEIN; RECOMBINANT PROTEIN; TISSUE PLASMINOGEN ACTIVATOR; TISSUE PLASMINOGEN ACTIVATOR CPG OLIGODEOXYNUCLEOTIDE ALANYLLYSYLPHENYLALANYLVALYLALANYLALANYLTRYPTOPHANYLTHREONYLLEUCYLLYSYLALANYLALANYLALANINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CPG ISLAND; CYTOKINE PRODUCTION; DRUG DESIGN; DRUG MECHANISM; DRUG RESPONSE; EPIDEMIC ENCEPHALITIS; FEMALE; HUMORAL IMMUNITY; IMMUNOGENICITY; IMMUNOSTIMULATION; JAPANESE ENCEPHALITIS VIRUS; MOUSE; NONHUMAN; TH1 CELL; TH2 CELL; VACCINE PRODUCTION; WESTERN BLOTTING;

ANIMALS; ANTIBODY FORMATION; DISEASE MODELS, ANIMAL; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; EPITOPES; FEMALE; IMMUNITY, CELLULAR; IMMUNIZATION; IMMUNIZATION, SECONDARY; MICE; MICE, INBRED BALB C; VACCINES, DNA; VIRAL VACCINES;

ESCHERICHIA COLI; EUKARYOTA; JAPANESE ENCEPHALITIS VIRUS; MUS; PROKARYOTA;

EID: 74649087203     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2008.09.019     Document Type: Article

References (57)

1. Abbas A.K., Murphy K.M., and Sher A. Functional diversity of helper T lymphocytes. Nature 383 (1996) 787-793
2. Alexander J., Fikes J., Hoffman S., Franke E., Sacci J., Appella E., Chisari F.V., Guidotti L.G., Chesnut R.W., Livingston B., and Sette A. The optimization of helper T lymphocyte (HTL) function in vaccine development. Immunology Research 18 (1998) 79-92
3. Andersen M.M., and Ronne T. Side-effects with Japanese encephalitis vaccine. Lancet 337 (1991) 1044
4. Ashok M.S., and Rangarajan P.N. Immunization with plasmid DNA encoding the envelope glycoprotein of Japanese encephalitis virus confers significant protection against intracerebral viral challenge without inducing detectable antiviral antibodies. Vaccine 18 (2000) 68-75
5. Ashok M.S., and Rangarajan P.N. Protective efficacy of a plasmid DNA encoding Japanese encephalitis virus envelope protein fused to tissue plasminogen activator signal sequences: studies in a murine intracerebral virus challenge model. Vaccine 20 (2002) 1563-1570
6. Barnett S.W., Rajasekar S., Legg H., Doeb B., Fullera D.H., Haynesa J.R., Walkerb C.M., and Steimerb K.S. Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit. Vaccine 15 (1997) 869-873
7. Biswas S., Reddy G.S., Srinivasan V.A., and Rangarajan P.N. Preexposure efficacy of a novel combination DNA and inactivated rabies virus vaccine. Human Gene Therapy 12 (2001) 1917-1922
8. Chambers T.J., Hahn C.S., Galler R., and Rice C.M. Flavivirus genome organization, expression, and replication. Annual Review of Microbiology 44 (1990) 649-688
9. Chia S.C., Leung P.S.C., Liao C.P., Haung J.H., and Lee S.T. Fragment of Japanese encephalitis virus protein produced in E. coli protects mice from virus challenge. Microbial Pathogenesis 31 (2001) 9-19
10. Doolan D.L., and Hoffman S.L. DNA-based vaccines against malaria: status and promise of multi-stage malaria DNA vaccine operation. International Journal for Parasitology 31 (2001) 753-762
11. Ge F., Qiu Y., Gao X., Yang Y., and Chen P. Fusion expression of major antigenic segment of JEV E protein-hsp70 and the identification of domain acting as adjuvant in hsp70. Veterinary Immunology and Immunopathology 113 (2006) 288-296
12. Ge F., Qiu Y., Yang Y., and Chen P. An hsp70 fusion protein vaccine potentiates the immune response against Japanese encephalitis virus. Archives of Virology 152 (2007) 125-135
13. Gourie-Devi M., and Deshpande D.S. Japanese encephalitis. In: Prasad L.S., and Kukzyeki L.L. (Eds). Paediatric Problems (1982), Chand, New Delhi, India 340-356
14. He X.S.S., Hu Z., Li J., Jiang L., Zhou F., Zhang Y., and Guo Y. Augmented humoral and cellular immune responses of a hepatitis B DNA vaccine encoding HBsAg by protein boosting. Vaccine 23 (2005) 1649-1656
15. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., and Akira S. A toll-like receptor recognizes bacterial DNA. Nature 408 (2000) 740-745
16. Igarashi A. Japanese encephalitis: virus, infection, and control. In: Kurstak E. (Ed). Control of Virus Diseases. second ed. (1992), Marcel Dekker, New York, USA 309-342
17. Johnson M.P., Meitin C.A., Bender B.S., and Small Jr. P.A. Passive immune serum inhibits antibody response to recombinant vaccinia virus. In: Ginsberg H., Brown F., Lerner R.A., and Chanock R.M. (Eds). Vaccines vol. 88 (1988), Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA 189-192
18. Jones T.R., Narum D.L., and Gozalo A.S. Protection of Aotus monkeys by Plasmodium falciparum EBA-175 region II DNA prime-protein boost immunization regimen. Journal of Infectious Diseases 183 (2001) 303-312
19. Kojima Y., Xin K.Q., Ooki T., Hamajimaa K., Oikawaa T., Shinodaa K., Ozakia T., Hoshinoa Y., Jounaia N., Nakazawab M., Klinmanc D., and Okuda K. Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine. Vaccine 20 (2002) 2857-2865
20. Kolaska A.S., and Kulkarni-Kale U. Prediction of three-dimensional structure and mapping of conformational epitopes. Virology 261 (1999) 31-42
21. Konishi E., Pincus S., Paoletti E., Shope R.E., and Mason P.W. Avipox virus vectored Japanese encephalitis virus vaccines: use as vaccine candidates in combination with purified subunit immunogens. Vaccine 12 (1994) 633-638
22. + cytotoxic T lymphocytes in mice. Virology 227 (1997) 353-360
23. Konishi E., Yamaoka M., Kurane I., and Mason P.W. Japanese encephalitis DNA vaccine candidates expressing premembrane and envelope genes induce virus-specific memory B cells and long-lasting antibodies in swine. Virology 268 (2000) 49-55
24. Konishi E., Ajiro N., Nukuzuma C., Mason P.W., and Kuranec I. Comparison of protective efficacies of plasmid DNAs encoding Japanese encephalitis virus proteins that induce neutralizing antibody or cytotoxic T lymphocytes in mice. Vaccine 21 (2003) 3675-3683
25. Konno J., Endo K., Agatsuma H., and Ishida N. Cyclic outbreaks of Japanese encephalitis among pigs and humans. American Journal of Epidemiology 84 (1966) 292-300
26. Krieg A.M. CpG motifs in bacterial DNA and their immune effects. Annual Review of Microbiology 20 (2002) 709-760
27. Kutubuddin M., Kolaskar A.S., Galande S., Gore M.M., Ghosh S.N., and Banerjee K. Recognition of helper T cell epitopes in envelope (E) glycoprotein of Japanese encephalitis, West Nile and Dengue viruses. Molecular Immunology 28 (1991) 149-154
28. Letvin N.L., Montefiori D.C., Yasutomi Y., Perry H.C., Davies M.-E., Lekutis C., Alroy M., Freed D.C., Lord C.I., Handt L.K., Liu M.A., and Shiver J.W. Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination. Proceedings of the National Academy of Sciences of the United States of America 94 (1997) 9378-9383
29. Lewis P.J., Cox G.J., Little-Vanden V., Hurk S., and Babiuk L.A. Polynucleotide vaccines in animals: enhancing and modulating responses. Vaccine 15 (1997) 861-864
30. Li Z.A., Howard C., Kelley G., Delogu F., Collins F., and Morris S. Immunogenicity of DNA vaccines expressing tuberculosis proteins fused to plasminogen activator signal sequences. Infection and Immunity 67 (1999) 4780-4786
31. Libraty D.H., Nisalak A., Endy T.P., Suntayakorn S., Vaughn D.W., and Innis B.L. Clinical and immunological risk factors for severe disease in Japanese encephalitis. Transactions of the Royal Society of Tropical Medicine and Hygiene 96 (2002) 173-178
32. Lin Y.L., Chen L.K., Liao C.L., Yeh C.T., Ma S.H., Chen J.L., Huang Y.L., Chen S.S., and Chiang H.Y. DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice. Journal of Virology 72 (1998) 191-200
33. McCown J., Cochran M., Putnak R., Feighny R., Burrons J., and Henchal E. Protection of mice against lethal Japanese encephalitis with a recombinant baculovirus vaccine. American Journal of Tropical Medicine and Hygiene 42 (1990) 491-499
34. Monath T.P. Pathobiology of aviviruses. In: Schlesinger S., and Schlesinger M.J. (Eds). Togaviridae and Aviviridae (1986), Plenum Press, New York, USA 375-440
35. Mosman T.R., and Coffman R.L. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Advances in Immunology 46 (1989) 111-147
36. Nyika A., Barbet A.F., Burridge M.J., and Mahan S.M. DNA vaccination with map1 gene followed by protein boost augments protection against challenge with Cowdria ruminantium, the agent of heartwater. Vaccine 20 (2002) 1215-1225
37. Olszewska W., and Steward M.W. Nasal delivery of epitope-based vaccines. Advanced Drug Delivery Reviews 51 (2001) 161-171
38. Oya A. Japanese encephalitis vaccine. Acta Pediatrics 30 (1988) 175-184
39. Plesner A.M., and Ronne T. Allergic mucocutaneous reactions to Japanese encephalitis vaccine. Vaccine 15 (1997) 1239-1243
40. Pugachev K.V., Mason P.W., Shope R.E., and Frey T.K. Double subgenomic sindbis virus recombinants expressing immunogenic proteins of Japanese encephalitis virus induce significant protection against lethal JEV infection. Virology 212 (1995) 587-594
41. Rauthan M., Kaur R., Appaiahgari M.B., and Vrati S. Oral immunization of mice with Japanese encephalitis virus envelope protein synthesized in Escherichia coli induces anti-viral antibodies. Microbes and Infection (2004) 1305-1311
42. Richmond J.F.L., Lu S., Santora J.C., Weng J., Hu S.L., and Montefiori D.C. Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type I Env antibody elicited by DNA priming and protein boosting. Journal of Virology 72 (1998) 9092-9100
43. Risini D.W., McCluskie M.J., Xu Y., and Davis H.L. CpG DNA induces stronger immune responses with less toxicity than other adjuvant. Vaccine 18 (2000) 1755-1762
44. Rothel J.S., Waterkeyn J.G., and Strugnell R.A. Nucleic acid vaccination of sheep: use in combination with a conventional adjuvanted vaccine against Taenia ovis. Immunology and Cell Biology 75 (1997) 41-46
45. Ruitenberg K.M., Walker C., Love D.N., Wellington J.E., and Whalley J.M. A prime-boost immunization strategy with DNA and recombinant baculovirus-expressed protein enhances protective immunogenicity of glycoprotein D of equine herpesvirus 1 in naive and infection-primed mice. Vaccine 18 (2000) 1367-1373
46. Scherer W.F., Moyer J., Izumi T., Gresser I., and McCown J. Ecologic studies of Japanese encephalitis virus in Japan. VI. Swine infection. American Journal of Tropical Medicine and Hygiene 8 (1959) 698-706
47. Schirmbeck R., and Reimann J. Alternative processing of endogenous or exogenous antigens extends the immunogenic, H-2 class I-restricted peptide repertoire. Molecular Immunology 39 (2002) 249-259
48. Schneeberger A., Wagner C., Zemann A., Lührs P., Kutil R., Goos M., Sting G., and Wagner S.N. CpG motifs are efficient adjuvants for DNA cancer vaccines. Journal of Investigative Dermatology 123 (2004) 371-379
49. Seif S.A., Morita K., Matsuo S., Hasebe F., and Igarashi A. Finger mapping of neutralizing epitope(s) on the C-terminal of Japanese encephalitis virus E-protein expressed in recombinant Escherichia coli system. Vaccine 13 (1995) 1515-1521
50. Sin J.I., Bagarazzi M., Pachuk C., and Weiner D.B. DNA priming-protein boosting enhances both antigen specific antibody and TH1-type cellular immune responses in a murine Herpes simplex virus-2 gD vaccine model. DNA Cell Biology 18 (1999) 771-779
51. + T cells provide help for B cell clonal expansion and antibody synthesis in a similar manner in vivo. Journal of Immunology 165 (2000) 3136-3144
52. + cytotoxic T lymphocytes. Archives of Virology 145 (2000) 523-534
53. Tanghe A., D'Souza S., Rosseels V., Denis O., Ottenhoff T.H.M., Dalemans W., Wheeler C., and Huygen K. Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting. Infection and Immunity 69 (2001) 3041-3047
54. Tsai T.F., Chang G.F., and Yu Y.X. Japanese encephalitis vaccines. In: Stanley A.P., and Oreustein W.A. (Eds). Vaccines. third ed. (1999), Saunders, Philadelphia, USA 672-710
55. Wu S.-C., and Lin C.-W. Neutralizing peptide ligands selected from phage-displayed libraries mimic the conformational epitope on domain III of the Japanese encephalitis virus envelope protein. Virus Research 76 (2001) 59-69
56. Wu S.-C., Lin Y.J., Chou J.W., and Lin C.W. Construction and characterization of a Fab recombinant protein for Japanese encephalitis virus neutralization. Vaccine 23 (2004) 163-171
57. Yasuda A., Kimura-Kuroda J., Ogimoto M., Miyarmito J., Sata T., and Sato T. Induction of protective immunity in animals vaccinated with recombinant vaccinia viruses that express preM and E glycoproteins of Japanese encephalitis virus. Journal of Virology 64 (1990) 2788-2795